We believe AEMD
's business model is unique in that its therapeutic systems could be used in conjunction with drugs or standalone, dramatically improving patient outcomes and saving lives.
) - Financial and Strategic SWOT Analysis Review
) has entered into an agreement with India's National Institute of Virology to begin testing of the Aethlon Hemopurifier as a candidate to treat Chikungunya, a debilitating mosquito-borne virus that is not addressed with proven antiviral drug or vaccine therapies, the company said on Thursday.
) has submitted a Humanitarian Use Device submission to the United States Food and Drug Administration to support potential market clearance of the Aethlon Hemopurifier as a treatment for Ebola virus, the company said on Thursday.
) has published an article describing the first treatment of Ebola with the company's Aethlon Hemopurifier, the company said on Thursday.
(NASDAQ: OTCQB: AEMD
), a company involved in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, announced yesterday that it has received independent internal review board approval to start human clinical studies of Hemopurifier therapy at DaVita MedCenter Dialysis, situated in Houston, Texas.